טוען...
A Peptoid Antagonist of VEGF Receptor 2 Recognizes A “Hotspot” In the Extracellular Domain Distinct From The Hormone-Binding Site
Antagonists of VEGF-mediated angiogenesis are of great interest clinically for the treatment of solid tumors and certain forms of macular degeneration. We recently described a novel peptoid antagonist of VEGF Receptor 2 (VEGFR2) that binds to the extracellular domain of the receptor and inhibits VEG...
שמור ב:
| Main Authors: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2008
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2460570/ https://ncbi.nlm.nih.gov/pubmed/18501615 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bmc.2008.05.015 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|